Centerra Gold to Announce Strategic Plans for U.S. Molybdenum Operations Amid Varied Market Performance,

Toronto, September 9, 2024' Centerra Gold Inc. (TSX: CG) (NYSE: CGAU), a prominent name in the mining sector, has announced that it will release the results from the Thompson Creek feasibility study and the strategic plan for its U.S. molybdenum operations after market close on Thursday, September 12, 2024. This includes an optimization plan for the Langeloth Metallurgical Facility. The company has scheduled a conference call and webcast for Friday, September 13, 2024, at 9:00 a.m. Eastern Time to discuss these developments in greater detail.

Molybdenum, often overshadowed by gold and silver in public discourse, plays a critical role in various industries due to its high melting point and strength. The Thompson Creek project is an important part of Centerra?s broader strategy to diversify beyond gold, leveraging its metallurgical processes in the U.S. to optimize production and cost-efficiency.

Centerra?s stock performance provides an interesting backdrop to this announcement. Over the past month, shares of Centerra Gold Inc. have displayed a 3.52% increase, outpacing broader market trends. However, the longer view is less favorable; over the past 12 months, Centerra shares have lagged significantly, trailing the market's 26.9% performance.

This discrepancy in short-term versus long-term performance may underpin the company's strategic realignment, as it seeks to bolster investor confidence and market position through strong operational results and future-oriented plans. The forthcoming feasibility study details and strategic plans are anticipated to provide deeper insights into Centerra's approach to optimally harnessing its molybdenum assets.

Investors, market analysts, and industry stakeholders will be keenly watching the upcoming revelations, particularly those concerning the Thompson Creek feasibility study and the Langeloth optimization plan. These details are likely to be pivotal in defining Centerra's strategic direction and financial health in the coming years.

Conference Call and Webcast Details:'

- Date: Friday, September 13, 2024

- Time: 9:00 a.m. Eastern Time

- Access: Specific details and links for joining the call and webcast are available on Centerra Gold Inc.'s official website.

The release of these critical reports and subsequent discussion underscores Centerra's commitment to transparency and strategic growth, particularly at a time when its market performance has been closely scrutinized.

More Centerra Gold Inc 's News

Centerra Gold Inc Centerra Golds Share Buyback Strategy: A Testament to Robust Growth and Shareholder Commitment, November 5, 2024

Centerra Gold Inc Centerra Gold Announces Quarterly Dividend of C$0.07 per Common Share October 31, 2024

Centerra Gold Inc Centerra Gold Unveils Feasibility Study for Thompson Creek Mine and Strategic Operations Plan for Molybdenum September 12, 2024

Centerra Gold Inc Centerra Gold Announces Quarterly Dividend, Boosting Investor Confidence August 1, 2024

Centerra Gold Inc TORONTO, July 18, 2024 - Centerra Gold Inc. (Centerra or the Company) (TSX CG) (NYSE CGAU) has made signifi... July 18, 2024

Centerra Gold Inc Centerra Gold Initiates Quarterly Dividend: Boosting Investor Confidence & Strengthening Market Standing May 14, 2024

Centerra Gold and Royal Gold Secure Sustainable Future for Mount Milligan Mine through Groundbreaking Agreement February 14, 2024

More Product Service News News

Product Service News Mustang Energy Soars to New Heights with Axiom Exploration A Game-Changer in Mineral Discovery, March 21, 2025

Product Service News Castor Maritime Inc. Navigates New Horizons with $28 Million Vessel Sale March 21, 2025

Product Service News VERBs Bold Move Launching a Three-Hour Marathon on Cheddar TV March 21, 2025

Submit

Previous News

US Productivity Surges with Decrease in Labor Costs: Promising Outlook for the Economy

Groundbreaking Submission to FDA ARS Pharmaceuticals Seeks Approval for Needle-Free Epinephrine for Pediatric Patients

Vine Hill Capital Investment Corp. Raises $200 Million in Landmark IPO, Set to Navigate the SPAC Landscape,

Trinity Biotech Advancements in Glucose Monitoring Signal Promising Future for Diabetes Management

Highwoods Properties Seals Strong Q3 Success with 738,000 SF in New Leases,

Major Order Secured by Actelis for U.S. Department of Aerial Transportation Amid Financial Challenges

Pulmonx Bolsters COPD Treatment with Groundbreaking AeriSeal Data at ERS Congress 2024 77.6% Patient ...

Innovations in Surgical Technologies Enovis Strengthens Leadership and Expands Product Portfolio

Kadant Inc. A Beacon for Work-Life Balance and Market Performance

Expensifys Strategic Moves Debt Elimination and Share Repurchase Amidst Market Fluctuations